NVEC

AI Memo

NVE

As of 2026-10-23/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-23 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

November dividend payment • 2026-11-30

Base target: $63 / p=50% prob

Biggest risk

The 8% quarterly revenue decline sharply contrasts with 36% first-half growth. A large medical-customer order adjustment and weak defense sales expose customer and procurement-cycle risk. The 33.68% October 22 share-price fall signals that investors may not accept the recovery outlook without evidence. [#SEC-8K-2026-10-21] [#EARNINGS-TRANSCRIPT-2027Q2] Price history

Invalidation

Break below $49 or thesis failure.

What would change my mind?

Management expects medical and defense sales to recover and second-half fiscal revenue to be consistent with the first half. New sensors and stronger distributor sales could diversify demand; the balance sheet held about $44.4 million of cash and marketable securities at September 30. [#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript [#SEC-8K-2026-10-21]

Research note

Recommendation

—

Confidence

medium

As of

2026-10-23

Base target

$63

p=50%

Bull target

$82

p=25%

Bear target

$49

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

New sensor sales broaden beyond large customers
Management expects medical and defense sales to recover and second-half fiscal revenue to be consistent with the first half.
New sensors and stronger distributor sales could diversify demand; the balance sheet held about $44.4 million of cash and marketable securities at September 30.

BearKey bullets

Defense sales are exposed to procurement timing; management reported a 95% fiscal-Q2 decline.
[#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript
Large-customer concentration and medical-device inventory adjustments can make orders volatile.

WatchKey bullets

November dividend payment

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $63 (p=50%)

Target spread vs base: +30% / -22%

Scenario probabilities

Bull Target: $82 (p=25%)Base Target: $63 (p=50%)Bear Target: $49 (p=25%)

Commentary

The stock closed October 22 at $68.36, down 33.68% from $103.07 on October 21; the earnings release and weak product sales were the immediate context, although the exact contribution of each concern cannot be isolated. Price history Post-release coverage No reliable consensus surprise or post-print analyst revisions were verified. Social, options, short-interest, and employee-sentiment measures were unavailable; their numeric placeholders above must not be interpreted as observed neutral readings.

As of 2026-10-23 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

New sensor sales broaden beyond large customers

Scenarios

Bull Target (Scenario probability)

$82 / p=25% prob

Base Target (Scenario probability)

$63 / p=50% prob

Bear Target (Scenario probability)

$49 / p=25% prob

Analysis 2026-10-23 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.55

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-11-30
November dividend payment
NVE declared a $1.00-per-share quarterly dividend payable November 30 to holders of record November 2. The payout supports income appeal, but one quarter's $0.65 diluted EPS did not cover the $1.00 dividend; sustained order weakness would test its durability. [#SEC-8K-2026-10-21] SEC-filed earnings release
Prob 95.00% • Move 2.00% • Priced-in 90.00%
EVENT2027-01-21
Medical and defense order recovery
Fiscal Q2 revenue fell 8% year over year to $5.83 million, including a 9% decline in product sales. On the earnings call, management attributed the product decline partly to a medical-customer inventory adjustment and a 95% drop in defense product sales, and said it expects both categories to recover in the current quarter. Whether orders actually return is the key test after the selloff. [#SEC-8K-2026-10-21] [#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript
Prob 55.00% • Move 10.00% • Priced-in 35.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

New sensor sales broaden beyond large customers
2027-10-23
Management reported 67% growth in distributor sales and described newly released wafer-level chip-scale and gear sensors for precision-motion applications. Larger, repeat orders would strengthen the diversification case, but robotics production timing and revenue scale remain unquantified. [#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript
Prob 40% • Move 15% • Priced-in 20%

Risks

Defense sales are exposed to procurement timing; management reported a 95% fiscal-Q2 decline. [#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript
Large-customer concentration and medical-device inventory adjustments can make orders volatile. [#EARNINGS-TRANSCRIPT-2027Q2] Earnings-call transcript
Quarterly dividend exceeded fiscal-Q2 diluted EPS; cash resources mitigate near-term risk but do not establish long-term coverage. [#SEC-8K-2026-10-21]
Tariffs, trade barriers, and uncertain end-market conditions are identified in the SEC-filed earnings release. [#SEC-8K-2026-10-21]

Peers

Symbol	Summary
INDI	Small-cap semiconductor size comparison only; its automotive focus is not a close match for NVE's spintronic sensors and couplers.
ASYS	Similar market-cap range but semiconductor equipment is a different business model. Neither candidate supplies a reliable direct valuation benchmark.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-23

Loading AI feed…

Symbol

Summary

INDI

Small-cap semiconductor size comparison only; its automotive focus is not a close match for NVE's spintronic sensors and couplers.

ASYS

Similar market-cap range but semiconductor equipment is a different business model. Neither candidate supplies a reliable direct valuation benchmark.